Halda Therapeutics Secures $126M to Advance Novel RIPTAC Cancer Therapies
Key Highlights Halda Therapeutics raises $126M in Series B extension, total $202M funding to date. Proceeds will advance…
Browsing Tag
Boxer Capital
3 posts
Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
Seismic Therapeutic Secures $121 Million in Series B Funding for Advanced Immunology Drug Development
Key Highlights Seismic Therapeutic, Inc., a machine learning immunology company, announces a $121 million Series B financing, led by Bessemer Venture…